ASTEC

Astec Lifesciences Share PriceAstec Lifesciences

₹1385.00
74.6 (5.69%)
  • Advice
  • Hold
As on 02 April, 2023 | 05:50 BSE: 533138 NSE: ASTEC

Astec Lifesciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Astec Lifesciences

Start SIP

Astec Lifesciences Share Price

  • Over 1 Month 2.57%
  • Over 3 Month -20.9%
  • Over 6 Month -25.23%
  • Over 1 Year -21.09%

Astec Lifesciences Key Statistics

P/E Ratio 36.9
PEG Ratio 9.2
Market Cap Cr 2,715
Price to Book Ratio 6.8
EPS 45.8
Dividend 0.1
Relative Strength Index 56.16
Money Flow Index 89.32
MACD Signal -61.37
Average True Range 75.94

Astec Lifesciences Investment Rating

  • Master Rating:
  • Astec Lifesciences has an operating revenue of Rs. 773.18 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 18% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Astec Lifesciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 117200184272
Operating Expenses Qtr Cr 105166159207
Operating Profit Qtr Cr 12332565
Depreciation Qtr Cr 98911
Interest Qtr Cr 6543
Tax Qtr Cr 06415
Net Profit Qtr Cr 1181143

Astec Lifesciences Technicals

EMA & SMA

Current Price
₹1385.
74.6 (5.69%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • 1286.42
  • 50 Day
  • 1403.31
  • 100 Day
  • 1552.77
  • 200 Day
  • 1655.95
  • 20 Day
  • 1287.39
  • 50 Day
  • 1396.99
  • 100 Day
  • 1639.34
  • 200 Day
  • 1790.36

Astec Lifesciences Resistance and Support

PIVOT
₹1237.6
Resistance
First Resistance 1383.2
Second Resistance 1456
Third Resistance 1601.6
RSI 56.16
MFI 89.32
MACD Single Line -61.37
MACD -46.57
Support
First Resistance 1164.8
Second Resistance 1019.2
Third Resistance 946.4

Astec Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 854,319 6,151,097 7.2
Week 315,232 3,587,334 11.38
1 Month 73,792 1,306,855 17.71
6 Month 38,296 1,370,631 35.79

Astec Lifesciences Result Highlights

Astec Lifesciences Synopsis

NSE-Chemicals-Agricultural

Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.
Market Cap 2,715
Sales 773
Shares in Float 0.65
No of funds 55
Yield 0.11
Book Value 6.85
U/D Vol ratio 0.4
LTDebt / Equity 13
Alpha -0.07
Beta 0.82

Astec Lifesciences

Owner NameDec-22Sep-22Jun-22
Promoters 66.77%66.77%65.29%
Mutual Funds 8.45%8.71%7.98%
Insurance Companies 2.26%
Foreign Portfolio Investors 2.19%1.53%0.48%
Financial Institutions/ Banks
Individual Investors 17.86%18.02%18.26%
Others 4.73%4.97%5.73%

Astec Lifesciences Management

Name Designation
Mr. Nadir B Godrej Chairman
Mr. Ashok V Hiremath Non Executive Director
Mr. Balram Singh Yadav Non Executive Director
Mr. Anurag Roy WholeTime Director & CEO
Dr. Brahma Nand Vyas Ind. Non-Executive Director
Mr. Vijay Kashinath Khot Ind. Non-Executive Director
Mr. R R Govindan Ind. Non-Executive Director
Mr. Nandkumar Dhekne Ind. Non-Executive Director
Ms. Anjali Gupte Independent Director
Mr. Burjis Nadir Godrej Non Exe.Non Ind.Director

Astec Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astec Lifesciences MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
Nippon India Multi Cap Fund - Growth 14092
ICICI Prudential Multicap Fund Growth 6929
ICICI Prudential Smallcap Fund Growth 4618
UTI Small Cap Fund Regular Growth 2391

Astec Lifesciences FAQs

What is Share Price of Astec Lifesciences ?

Astec Lifesciences share price is ₹1385 As on 02 April, 2023 | 05:36

What is the Market Cap of Astec Lifesciences ?

The Market Cap of Astec Lifesciences is ₹2715.4 Cr As on 02 April, 2023 | 05:36

What is the P/E ratio of Astec Lifesciences ?

The P/E ratio of Astec Lifesciences is 36.9 As on 02 April, 2023 | 05:36

What is the PB ratio of Astec Lifesciences ?

The PB ratio of Astec Lifesciences is 6.8 As on 02 April, 2023 | 05:36

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number